Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA: 600420)
China flag China · Delayed Price · Currency is CNY
12.28
-0.19 (-1.52%)
Nov 15, 2024, 3:00 PM CST

Shanghai Shyndec Pharmaceutical Company Description

Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, raw materials, and pharmaceutical preparations in China and internationally.

The company’s pharmaceutical intermediate products primarily includes 7-ACA, 6-APA, penicillin industrial salt, etc.; API products for anti-infection applications comprising azithromycin, amoxicillin, potassium clavulanate, ceftriaxone sodium, etc., as well as urine source biochemical products and other characteristic raw materials; pharmaceutical preparations, such as cardiovascular and cerebrovascular drugs that comprises enalapril maleate tablets and nifedipine controlled-release tablets; and anti-aging drugs, including cefuroxime axetil and cefuroxime sodium; and metabolic and endocrine drugs consist if methylprednisolone sodium succinate through injections.

Its products portfolio covers systemic anti-infection, heart and brain blood vessels, anti-tumor and immunomodulators, central nervous system, hormones, genitourinary system, digestive tract and metabolism, respiratory system, and other therapeutic areas in various dosage forms, such as tablets, capsules, powder injections, small volume injections, granules, suspensions, suppositories, and ointments.

The company also offers animal vaccines and general health products. Shanghai Shyndec Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Shanghai, China.

Shanghai Shyndec Pharmaceutical Co., Ltd.
Country China
Founded 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 11,608
CEO Yong Liu

Contact Details

Address:
No. 378, Jianlu Road
Shanghai, 200137
China
Phone 86 21 6251 0990
Website shyndec.com

Stock Details

Ticker Symbol 600420
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE000001JG2
SIC Code 2834

Key Executives

Name Position
Yong Liu Vice Chairman of the Board and President
Xian Lin Li Vice President and General Counsel
Dongsong Wei Vice President and Secretary of the Board of Directors
Feng Ni Vice President
Jing Zu Chief Financial Officer